Narwhal Capital Management Abbott Laboratories Transaction History

Narwhal Capital Management

  • $1.09 Billion
  • Q4 2024

A detailed history of Narwhal Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Narwhal Capital Management holds 51,473 shares of ABT stock, worth $6.61 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
51,473
Previous 22,338 130.43%
Holding current value
$6.61 Million
Previous $2.55 Million 128.67%
% of portfolio
0.53%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
BUY
$111.93 - $119.39 $3.26 Million - $3.48 Million
29,135 Added 130.43%
51,473 $5.82 Million
Q3 2024

Oct 22, 2024
BUY
$100.07 - $118.13 $18,412 - $21,735
184 Added 0.83%
22,338 $2.55 Million
Q2 2024

Aug 05, 2024
SELL
$100.73 - $112.44 $28,405 - $31,708
-282 Reduced 1.26%
22,154 $2.3 Million
Q1 2024

Apr 26, 2024
SELL
$109.52 - $120.96 $931,467 - $1.03 Million
-8,505 Reduced 27.49%
22,436 $2.55 Million
Q4 2023

Jan 24, 2024
BUY
$90.19 - $110.4 $697,439 - $853,723
7,733 Added 33.32%
30,941 $3.41 Million
Q3 2023

Oct 27, 2023
SELL
$95.53 - $114.62 $775,225 - $930,141
-8,115 Reduced 25.91%
23,208 $2.25 Million
Q2 2023

Aug 02, 2023
SELL
$100.78 - $112.29 $455,324 - $507,326
-4,518 Reduced 12.61%
31,323 $3.41 Million
Q1 2023

May 01, 2023
SELL
$96.86 - $114.01 $52,207 - $61,451
-539 Reduced 1.48%
35,841 $3.63 Million
Q4 2022

Jan 30, 2023
SELL
$95.06 - $111.52 $74,146 - $86,985
-780 Reduced 2.1%
36,380 $3.99 Million
Q3 2022

Oct 31, 2022
SELL
$96.76 - $112.03 $1.24 Million - $1.44 Million
-12,851 Reduced 25.7%
37,160 $3.6 Million
Q2 2022

Aug 01, 2022
SELL
$102.07 - $123.37 $1.08 Million - $1.31 Million
-10,598 Reduced 17.49%
50,011 $5.43 Million
Q1 2022

Apr 26, 2022
SELL
$114.02 - $139.04 $5.31 Million - $6.48 Million
-46,601 Reduced 43.47%
60,609 $7.17 Million
Q4 2021

Jan 26, 2022
SELL
$115.53 - $141.46 $883,111 - $1.08 Million
-7,644 Reduced 6.66%
107,210 $15.1 Million
Q3 2021

Oct 22, 2021
BUY
$116.66 - $129.06 $254,435 - $281,479
2,181 Added 1.94%
114,854 $13.6 Million
Q2 2021

Jul 29, 2021
BUY
$105.79 - $124.53 $167,888 - $197,629
1,587 Added 1.43%
112,673 $13.1 Million
Q1 2021

Apr 23, 2021
SELL
$108.84 - $128.23 $277,106 - $326,473
-2,546 Reduced 2.24%
111,086 $13.3 Million
Q4 2020

Feb 02, 2021
BUY
$105.0 - $114.42 $1.61 Million - $1.76 Million
15,380 Added 15.65%
113,632 $12.4 Million
Q3 2020

Oct 26, 2020
BUY
$91.64 - $111.29 $84,217 - $102,275
919 Added 0.94%
98,252 $10.7 Million
Q2 2020

Jul 22, 2020
BUY
$76.57 - $98.0 $69,602 - $89,082
909 Added 0.94%
97,333 $8.9 Million
Q1 2020

Apr 30, 2020
BUY
$62.82 - $91.86 $1.44 Million - $2.1 Million
22,894 Added 31.14%
96,424 $7.61 Million
Q4 2019

Jan 31, 2020
BUY
$78.51 - $87.4 $24,416 - $27,181
311 Added 0.42%
73,530 $6.39 Million
Q3 2019

Oct 31, 2019
BUY
$81.84 - $88.74 $794,011 - $860,955
9,702 Added 15.27%
73,219 $6.13 Million
Q2 2019

Jul 30, 2019
BUY
$72.88 - $85.0 $304,419 - $355,045
4,177 Added 7.04%
63,517 $5.34 Million
Q1 2019

Apr 12, 2019
SELL
$66.22 - $80.06 $166,543 - $201,350
-2,515 Reduced 4.07%
59,340 $4.74 Million
Q4 2018

Jan 15, 2019
SELL
$65.56 - $74.27 $43,597 - $49,389
-665 Reduced 1.06%
61,855 $4.47 Million
Q3 2018

Oct 23, 2018
SELL
$60.81 - $73.36 $6,081 - $7,336
-100 Reduced 0.16%
62,520 $4.59 Million
Q2 2018

Jul 19, 2018
BUY
$57.57 - $63.54 $171,846 - $189,666
2,985 Added 5.01%
62,620 $3.82 Million
Q1 2018

Apr 17, 2018
BUY
$56.27 - $63.62 $769,098 - $869,558
13,668 Added 29.73%
59,635 $3.57 Million
Q4 2017

Jan 23, 2018
BUY
$53.68 - $57.47 $2.47 Million - $2.64 Million
45,967
45,967 $2.62 Million

Others Institutions Holding ABT

# of Institutions
3,228
Shares Held
1.3B
Call Options Held
8.71M
Put Options Held
8.03M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $225B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Narwhal Capital Management Portfolio

Follow Narwhal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Narwhal Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email